This announcement is a separate document:
金陵药业:金陵药业股份有限公司2024年第四次独立董事专门会议的审查意见
Jinling Pharmaceutical: Review Opinions of the Fourth Special Meeting of Independent Directors of Jinling Pharmaceutical Co., Ltd. in 2024
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.